332 related articles for article (PubMed ID: 11057330)
21. Investigations of new drugs in combination with cisplatin in stage III non-small cell lung cancer.
Vokes EE; Leopold KA; Herndon J; Green MR
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-42-S8-45. PubMed ID: 9207317
[TBL] [Abstract][Full Text] [Related]
22. The combination of cisplatin and vinorelbine with concurrent thoracic radiation therapy for locally advanced stage IIIA or IIIB non-small-cell lung cancer.
Hirose T; Mizutani Y; Ohmori T; Ishida H; Hosaka T; Ando K; Shirai T; Okuda K; Ohnishi T; Horichi N; Kubota H; Adachi M
Cancer Chemother Pharmacol; 2006 Sep; 58(3):361-7. PubMed ID: 16331494
[TBL] [Abstract][Full Text] [Related]
23. [Daily low-dose cisplatin plus concurrent high-dose thoracic radiotherapy in elderly patients with locally advanced unresectable non-small-cell lung cancer].
Nakano K; Yamamoto M; Iwamoto H; Hiramoto T
Gan To Kagaku Ryoho; 2003 Sep; 30(9):1283-7. PubMed ID: 14518407
[TBL] [Abstract][Full Text] [Related]
24. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
25. [A randomized comparison of radiotherapy with CAP and CVP in non-small cell lung cancer].
Yoneda S; Homma T; Yoshida S; Noguchi Y; Fukuda Y; Nakata M; Sakura M
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2870-1. PubMed ID: 3019254
[No Abstract] [Full Text] [Related]
26. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
Imaizumi M;
Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of oral S-1 plus Cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Kaira K; Sunaga N; Yanagitani N; Kawata T; Utsugi M; Shimizu K; Ebara T; Kawamura H; Nonaka T; Ishikawa H; Sakurai H; Suga T; Hara K; Hisada T; Ishizuka T; Nakano T; Mori M
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):109-14. PubMed ID: 18929446
[TBL] [Abstract][Full Text] [Related]
28. [Polychemoradiation treatment of non-small cell lung cancer].
Linchenko IF; Danil'ian Vm
Med Radiol (Mosk); 1985 Aug; 30(8):64-9. PubMed ID: 2993782
[No Abstract] [Full Text] [Related]
29. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
[TBL] [Abstract][Full Text] [Related]
30. [Trial of combined radiotherapy and low-dose carboplatin for non-small cell lung cancer].
Kaneko T; Okagawa K; Mizunoya S; Nishiyama K; Ikeda T; Ito M
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1401-3. PubMed ID: 8394064
[No Abstract] [Full Text] [Related]
31. A retrospective study of concurrent chemoradiation using mitomycin, vinblastine and cisplatin chemotherapy for non-small cell lung cancer.
Newman G
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):728. PubMed ID: 19628378
[No Abstract] [Full Text] [Related]
32. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
Mornex F
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
[No Abstract] [Full Text] [Related]
33. Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer.
Vokes EE; Crawford J; Bogart J; Socinski MA; Clamon G; Green MR
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5045s-5050s. PubMed ID: 16000612
[TBL] [Abstract][Full Text] [Related]
34. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
Sekine I; Sumi M; Ito Y; Tanai C; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Jpn J Clin Oncol; 2009 Nov; 39(11):707-12. PubMed ID: 19692418
[TBL] [Abstract][Full Text] [Related]
35. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
[TBL] [Abstract][Full Text] [Related]
36. Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.
Hirose T; Yamaoka T; Ohnishi T; Sugiyama T; Kusumoto S; Shirai T; Okuda K; Ohmori T; Adachi M
Psychooncology; 2009 May; 18(5):483-9. PubMed ID: 18942662
[TBL] [Abstract][Full Text] [Related]
37. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
[TBL] [Abstract][Full Text] [Related]
38. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
Pourel N; Santelmo N; Naafa N; Serre A; Hilgers W; Mineur L; Molinari N; Reboul F
Eur J Cardiothorac Surg; 2008 May; 33(5):829-36. PubMed ID: 18367406
[TBL] [Abstract][Full Text] [Related]
39. [Bronchial arterial infusion chemotherapy with or without radiotherapy for advanced lung cancer].
Huang DP
Zhonghua Zhong Liu Za Zhi; 1990 May; 12(3):216-8. PubMed ID: 2249598
[TBL] [Abstract][Full Text] [Related]
40. Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life.
Schumacher A; Riesenbeck D; Braunheim M; Wewers D; Heinecke A; Semik M; Hoffknecht P; Macha HN; Klinke F; Schmidt EW; Willich N; Berdel WE; Thomas M;
Lung Cancer; 2004 Apr; 44(1):89-97. PubMed ID: 15013587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
